Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Konstantina Chamoulkou"'
Autor:
Gerasimos Pangalis, Aikaterini Bitsani, Annita Ioanna Gkioka, Ioannis Grafakos, Paraskevi Papaioannou, Argyrios Tsantes, Styliani I. Kokori, Thommais Tryfou, Panayiotis Panayiotidis, Sotirios Sachanas, Konstantina Chamoulkou, Anastasia Kopsaftopoulou, Maria Dimou, Panagiotis Repousis, Aspasia Koudouna, Marie-Christine Kyrtsonis, Dimitrios Maltezas
Publikováno v:
Blood. 132:5547-5547
CLL is a frequent and usually indolent disease that require only follow-up in about 2/3 of patients while the rest 1/3 of patients are symptomatic, have a worse outcome and need to be treated. The role of angiogenesis in CLL prognosis remains unclear
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d0adf75a4a0cbd6257976b8433659390
https://doi.org/10.1182/blood-2018-99-119520
https://doi.org/10.1182/blood-2018-99-119520
Autor:
Annita Ioanna Gkioka, Theodoros Iliakis, Anastasia Kopsaftopoulou, Maria Dimou, Aspasia Koudouna, Kallirroi Tsalimalma, Marie-Christine Kyrtsonis, Paraskevi Papaioannou, Petros P. Sfikakis, Nikolitsa Kafassi, Aikaterini Bitsani, Panayiotis Panayiotidis, Ioannis Grafakos, Konstantina Chamoulkou
Publikováno v:
Blood. 132:5584-5584
SMM may have an indolent course and remain stable for years; however, some patients evolve to MM requiring treatment within two years or less. To timely recognize these patients, three biomarkers (FLCR>100, ≥1 osteolysis and ≥60% plasma cell bone
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b608bb6b20096bca65eac1b6305690c2
https://doi.org/10.1182/blood-2018-99-118631
https://doi.org/10.1182/blood-2018-99-118631